Here we present a protocol to study intracellular protein-protein interactions that is based on the widely used biotin-avidin pull-down system. The modification presented includes the combination of this technique with cell-penetrating sequences. We propose to design cell-penetrating baits that can be incubated with living cells instead of cell lysates and therefore the interactions found will reflect those that occur within the intracellular context. Connexin43 (Cx43), a protein that forms gap junction channels and hemichannels is down-regulated in high-grade gliomas. The Cx43 region comprising amino acids 266-283 is responsible for the inhibition of the oncogenic activity of c-Src in glioma cells. Here we use TAT as the cell-penetrating sequence, biotin as the pull-down tag and the region of Cx43 comprised between amino acids 266-283 as the target to find intracellular interactions in the hard-to-transfect human glioma stem cells. One of the limitations of the proposed method is that the molecule used as bait could fail to fold properly and, consequently, the interactions found could not be associated with the effect. However, this method can be especially interesting for the interactions involved in signal transduction pathways because they are usually carried out by intrinsically disordered regions and, therefore, they do not require an ordered folding. In addition, one of the advantages of the proposed method is that the relevance of each residue on the interaction can be easily studied. This is a modular system; therefore, other cell-penetrating sequences, other tags, and other intracellular targets can be employed. Finally, the scope of this protocol is far beyond protein-protein interaction because this system can be applied to other bioactive cargoes such as RNA sequences, nanoparticles, viruses or any molecule that can be transduced with cell-penetrating sequences and fused to pull-down tags to study their intracellular mechanism of action.
Introduction
Protein-protein interactions are essential for a great variety of cellular processes. To fully understand these processes, methods for identifying protein interactions within the complex intracellular environment are required. One of the most used methods to identify interaction partners of a protein is to use that protein or a mimetic peptide of a part of that protein as bait in affinity pull-down experiments followed by detection of binding proteins. The avidin-biotin system is frequently used because of the high affinity, specificity and stable interaction between avidin and biotin 1, 2 . Usually, biotin is covalently bound to the bait (protein or peptide) and after a period of incubation with the cell lysates to allow the establishment of interactions, the biotinylated bait bound to its intracellular partners is pulled down with avidin or avidin derivatives conjugated with support beads. Then, bait-protein interactions are detected after washing, elution, and analysis by denaturing electrophoresis followed by Western blot. One of the problems of this technique is that the interactions between the protein of interest and its intracellular partners are taking place outside of the cellular context. This is especially important for the interactions involved in signal transduction pathways because they take place in specific intracellular locations, they are transient and they are typically carried out by not abundant proteins. Therefore, within the cell lysates these interactions can be masked by other more abundant proteins or by proteins that usually are not in close proximity.
Cell-penetrating peptides (CPPs) are short peptides (≤40 amino acids), composed mostly by cationic amino acids that are capable of transporting a wide range of molecules into almost any cell 3 . Cargoes such as proteins, plasmid DNA, siRNA, viruses, imaging agents, and various nanoparticles have been conjugated to CPPs and efficiently internalized 4, 5 . Because of this transporting ability they are also known as protein transduction domains (PTDs), membrane translocating sequences (MTSs), and Trojan peptides. Among the CPPs, the TAT peptide from the HIV transactivator protein TAT 6 has been one of the most widely studied 7, 8, 9 . TAT is a nonapeptide that contains 6 arginine and 2 lysine residues and consequently is highly cationic. Substitution studies have demonstrated that the net positive charge of TAT is necessary for electrostatic interactions with the plasma membranes of eukaryotic cells and its subsequent internalization 10 . Similarly to other CPPs, positivelycharged TAT strongly binds electrostatically to the various negatively-charged species present at the extracellular surface of cell membranes, including lipid head groups, glycoproteins and proteoglycans 3, 10 1. Centrifuge the 1.5 mL tubes at 11,000 x g for 10 min at 4 °C. 
Western Blot
NOTE: Western blotting was performed as previously described 24 .
1. Load equivalent volume of each sample per lane on Bis-Tris (4-12%) midigels in a Midi-Cell Electrophoresis System. 2. Transblot proteins using a dry blotting system into a nitrocellulose regular stack. 3. Stain the membrane with 10% Ponceau for 10 min. 4. Wash the membranes 3 x 5 min with 5 mL of TTBS. 5. Block the membranes with 7% milk in TTBS for 1 h with gentle shaking in tubes or small boxes. Make sure the volume used is enough to cover the membranes and that they do not dry, i.e. 40 mL per whole midi membrane. 6. Wash 3 x 5 min with 5 mL of TTBS. 7. Incubate overnight at 4 °C with the primary antibody against the protein of interest with gentle shaking. 8. Wash 3 x 5 min with 5 mL of TTBS. 9. Incubate the membrane at room temperature with the correspondent peroxidase-conjugated secondary antibody in TTBS for 1 h. 10. Wash 3 x 5 min with 5 mL of TTBS. 11. Develop with a chemiluminescent substrate in a chemiluminescence system. ) with mild shaking. 4. Measure the absorbance at a wavelength of 570 nm using a microplate reader.
Problem Solving

Other Techniques Used in this Article
Representative Results
Before using BCPPs to study intracellular interaction, it is critical to compare the effects of BCPP vs CPP to validate the results obtained with BCPP. Consequently, to study whether the inclusion of biotin modifies the activity of the target sequence, we first analyzed the effect of TATCx43 266-283 -B compared with TAT-Cx43 266-283 on G166 GSCs morphology. To do so, we performed some immunofluorescence analyses of two cytoskeletal proteins, F-actin and α-tubulin after 24 h of treatment. Figure 1 shows that G166 GSCs in the presence of 50 µM TAT-Cx43 266-283 or TAT-Cx43 266-283 -B acquire a more rounded shape compared to the elongated and expanded cellular prolongations shown in the controls (TAT or TAT-B). In fact, Figure 1b shows that actin filaments are mostly assembled as actin networks when the cells were treated with TATCx43 266-283 or TAT-Cx43 266-283 -B while they form more actin bundles in the control cells (treated with TAT or TAT-B) 25 . In contrast, α-tubulin distribution does not vary between the different conditions. These results showed that the presence of biotin did not modify the effect of the target sequence on the morphology of G166 GSCs. In previous studies 20, 21 , we showed that TAT-Cx43 266-283 reduced G166 GSCs proliferation. In this study, we investigated whether TAT-Cx43 266-283 -B exerts the same effects in the growth as TAT-Cx43 266-283 . To do so, we analyzed the G166 GSCs proliferation by MTT assay after 72 h of treatment. The MTT assay is a colorimetric assay for assessing cell metabolic activity. MTT is metabolized by NAD(P)H oxidoreductase enzymes in mitochondria reflecting the number of viable cells present. Figure 2 shows that the reduction in the G166 GSCs cell viability is not significantly different when cells were treated with 50 µM TAT-Cx43 266-283 or 50 µM TATCx43 266-283 -B. Indeed, both significantly diminished G166 GSCs proliferation as compared to the control, TAT or TAT-B.
Once we confirmed that the effect of our target sequence in G166 GSCs (TAT-Cx43 266-283 ) was not modified by the inclusion of biotin at the Cterminus (TAT-Cx43 266-283 -B), we investigated the intracellular partners of this sequence following the protocol described in this study ( Figure  3) . Because caveolae have been involved in the mechanism of TAT internalization 26 , we analyzed the presence of caveolin-1 (Cav-1) in the pulldowns. Western blot analysis (Figure 4) showed that TAT-B and TAT-Cx43 266-283 -B interact with Cav-1. However, the ability of TAT-Cx43 266-283 -B to recruit c-Src, PTEN and CSK is stronger than that found with TAT-B. Focal adhesion kinase (FAK) is a substrate of c-Src that has not been shown to interact with Cx43. Indeed, FAK did not show any significant interaction with either TAT-B or TAT-Cx43 266-283 -B.
To confirm the interaction between TAT-Cx43 266-283 -B and c-Src, G166 GSCs were incubated with 50 µM TAT-Cx43 266-283 -B for 30 min and their localization was followed with fluorescent streptavidin by confocal microscopy ( Figure 5) . Our results showed that the intracellular distribution of TAT-Cx43 266-283 -B is close to the plasma membrane (shown by phosphatidylserine staining) and matches with that of c-Src. In fact, colocalization analyses revealed some points of co-localization (white) between TAT-Cx43 266-283 -B and c-Src in the merge image. Consequently, confocal microscopy studies confirm the results obtained with the BCPP pull-down protocol described in this study. 
Discussion
There are many methods to study protein-protein interactions. The method presented in this study is based on the widely used biotin-avidin pulldown system in which a biotinylated bait is incubated with cell lysates to allow the establishment of interactions. The modification presented in this study includes the combination of this technique with cell-penetrating sequences. We propose to design cell-penetrating baits that can be incubated with living cells instead of cell lysates and therefore the interactions found will reflect those that occurred within the cellular context.
Here we use TAT as the cell-penetrating sequence, biotin as the pull-down tag and the region of Cx43 comprised between amino acids 266-283 as the target to find intracellular interactions in human GSCs. The structural basis for the interaction between Cx43 and c-Src is well known 11, 12 . This is an important interaction because it inhibits the oncogenic activity of c-Src in glioma cells 24, 13 . In fact, CPPs containing this region (TATCx43 266-283 ) mimic the antioncogenic properties of Cx43 on glioma cells 19, 20, 21 . In rat glioma C6 cells, the mechanism by which TAT-Cx43 266-283 inhibits c-Src includes the recruitment of c-Src together with its endogenous inhibitors CSK and PTEN 20 . It should be mentioned that GSCs are very interesting as a target in glioma therapy, because they constitute a subpopulation that is resistant to conventional treatments and therefore responsible for the recurrence of this malignant brain tumors 27 . Furthermore, they are hard-to-transfect cells and therefore the study of intracellular interactions becomes more difficult. CPPs are rapidly and efficiently internalized in GSCs 19 favoring their use for the study of intracellular interactions. In this study, using CPPs fused to biotin we confirm the interaction of the Cx43 266-283 sequence with c-Src together with its endogenous inhibitors CSK and PTEN in human GSCs.
This method is very powerful to study the intracellular mechanism of bioactive compounds. However, it is very important to confirm that the biological effect of the biotinylated cell penetrating bait is not different from that obtained with the non-biotinylated one. This step is required to associate the interactions found with the effect of the bioactive compound. In addition, the stability of the compound, its possible degradation by proteases as well as its possible toxicity, should be carefully tested and taken into account before planning the experiment. In the example presented, the anti-proliferative effect of TAT-Cx43 266-283 on G166 human GSCs has been previously documented 20 . In this study, we confirm that the anti-proliferative effect of TAT- these results indicate that the inclusion of biotin at the c-terminus of TAT-Cx43 266-283 did not modify the effects of this compound on human GSCs. However, if biotin would modify the effects of the bioactive molecule, other tags for protein purification can be tested, such as the FLAG octapeptide (DYKDDDDK) 28 , the human influenza hemagglutinin-derived tag HA (YPYDVPDYA) or glutathione S-transferase (GST) 29 . Similarly, if TAT does not target the cell population of interest, other cell penetrating sequences, such as penetratin, MPG (for a review, see 30 ) or cell specific sequences can be used 31 .
In addition to study proteins that specifically interact with the target sequence, ideally, the presence of proteins that interact with both the control and the target sequence and proteins that do not interact with them, as positive and negative controls, should be addressed. In this sense, we found Cav-1 in the control and treated situation, suggesting that the caveolae have been involved in the mechanism of internalization, as it has been previously shown 26 . Furthermore, FAK, which interacts with c-Src but is supposed not to interact with the Cx43 c-terminal, was absent in both the control and treated situation. These results reinforce the specificity of the interaction between TAT-Cx43 266-283 -B , c-Src, CSK and PTEN.To confirm the results obtained with this protocol, confocal microscopy can be used to visualize the distribution of the interacting proteins and to study their co-localization. Thus, we found that TAT-Cx43 266-283 -B and c-Src exhibit a similar intracellular distribution with some points of co-localization confirming the results obtained with the pull-down experiments. In fact, TAT-Cx43 266-283 -B is distributed close to the plasma membrane suggesting that the cargo, in this study Cx43 [266] [267] [268] [269] [270] [271] [272] [273] [274] [275] [276] [277] [278] [279] [280] [281] [282] [283] , directs the molecule to its intracellular partners.
One of the limitations of the proposed method is that the molecule used as bait could fail to fold properly and the expected effects would not be found. In this situation, the interactions found could not be associated to the effect. However, this method can be especially interesting for the interactions involved in signal transduction pathways because they are usually carried out by intrinsically disordered regions 32 and therefore they do not require an ordered folding. In addition, one of the advantages of the proposed method is that the time course of the interaction can be followed, which is especially relevant for transient interactions. Furthermore, the relevance of each residue on the interaction can be easily studied. Indeed, it is possible to study the relevance of posttranslational modifications on protein-protein interaction, for instance, by phosphomimetic substitution of glutamate for serine or threonine. Similarly, substitution of serine or threonine for alanine or tyrosine for phenylalanine allows testing the effect of non-phosphorylatable serine, threonine or tyrosine. To mimic phospho-tyrosine, the most accurate way is the substitution of Tyr for p-Tyr
33
.
Finally, the scope of this protocol is far beyond protein-protein interaction because this system can be applied to other bioactive cargoes such as RNA sequences, nanoparticles, viruses or other molecules that can be fused to biotin and transduced with CPP to study their intracellular mechanism of action.
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